Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Mankin

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 10, 2011
ROCK1 as a potential therapeutic target in osteosarcomaXianzhe Liu, Edwin Choy, Francis J Hornicek, et al.
Molecular Cancer Therapeutics|July 30, 2009
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.
Molecular Cancer Therapeutics|May 22, 2016
Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelXianzhe Liu, Yan Gao, Jacson Shen, et al.
Plos One|September 11, 2009
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.
Spine|April 14, 2010
Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordomaCao Yang, Francis J Hornicek, Kirkham B Wood, et al.
Cancer Letters|September 7, 2013
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cellsBin Jia, Edwin Choy, Gregory Cote, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 5, 2008
Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expressionCao Yang, Shuhua Yang, Kirkham B Wood, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cellsCao Yang, Edwin Choy, Francis J Hornicek, et al.
Anticancer Research|April 22, 2011
Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell linesCao Yang, Edwin Choy, Francis J Hornicek, et al.
International Journal of Cancer|April 24, 2015
Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosisXiaoqian Yang, Jacson Shen, Yan Gao, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 10, 2011
ROCK1 as a potential therapeutic target in osteosarcomaXianzhe Liu, Edwin Choy, Francis J Hornicek, et al.
Molecular Cancer Therapeutics|July 30, 2009
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.
Molecular Cancer Therapeutics|May 22, 2016
Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelXianzhe Liu, Yan Gao, Jacson Shen, et al.
Plos One|September 11, 2009
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell linesZhenfeng Duan, Edwin Choy, David Harmon, et al.
Spine|April 14, 2010
Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordomaCao Yang, Francis J Hornicek, Kirkham B Wood, et al.
Cancer Letters|September 7, 2013
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cellsBin Jia, Edwin Choy, Gregory Cote, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 5, 2008
Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expressionCao Yang, Shuhua Yang, Kirkham B Wood, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cellsCao Yang, Edwin Choy, Francis J Hornicek, et al.
Anticancer Research|April 22, 2011
Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell linesCao Yang, Edwin Choy, Francis J Hornicek, et al.
International Journal of Cancer|April 24, 2015
Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosisXiaoqian Yang, Jacson Shen, Yan Gao, et al.
Pageof 6